NCT00680472

HKT-500 in Adult Patients With Shoulder Pain

Protocol HKT-500-US08: A Randomized, Multicenter, Double-blind, Placebo-controlled, Two-week Study to Assess the Efficacy and Safety of HKT-500 in Subjects With Acute Shoulder Pain

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 368 (actual)
• Sponsor: Hisamitsu Pharmaceutical Co., Inc. · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The objective of this study is to determine the efficacy of HKT-500 in subjects with acute shoulder pain

Detailed description

Randomized, double-blind, placebo-controlled, multicenter study in men and women 18 years of age or greater who have acute shoulder pain requiring analgesic treatment daily for at least 2 weeks.

Conditions

• Pain

Interventions

Type	Name	Description
DRUG	HKT-500 Ketoprofen Topical Patch	HKT-500 Ketoprofen Topical Patch
OTHER	Placebo Patch	Treatment with Placebo Patch

Timeline

• Start date: 2008-04-01
• Primary completion: 2008-10-01
• Completion: 2008-10-01
• First posted: 2008-05-20
• Last updated: 2015-06-04

Locations

35 sites across 1 country: United States